| Systematic (IUPAC) name | |
|---|---|
| 3,5-diethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 103890-78-4 |
| ATC code | C08CA09 |
| PubChem | CID 5311217 |
| UNII | 260080034N |
| KEGG | D04657 |
| Chemical data | |
| Formula | C26H33NO6 |
| Mol. mass | 455.543 g/mol |
| |
|
Lacidipine (tradenames Lacipil (GSK) or Motens (Boehringer Ingelheim)) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
Here you can share your comments or contribute with more information, content, resources or links about this topic.